• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.

    Author

    • Dr. Vijay Singh Yadav, Dr. Yogesh, Dr. B. K sevatkar, Dr. Preeti gawali

    INDIA

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background: Melasma is a photo-exposed hypermelanosis defined by dark brownish maculae with irregular shapes but clear borders on the face, forehead, and temples, and less often on the nose, eyelids, chin, and upper lips. As a result of air pollution, habits of using different cosmetics, stressed lifestyles, and nutritional changes and so on, many skin disorders, including melasma, are seen in our everyday lives.
Aims and objective: To conduct a clinical study on raktadushṭi nidana in Vyanga. To conduct upashayatmaka (clinical) trial to assess the efficacy of Kinshukadi taila and Vatapatradi lepa in the management of Vyanga.
Material and methods: Total 100 patients were registered for the study, but 92 patients had completed the trial. : Kinshukadi Taila and Vatapatradi Lepa duration of the therapy for each group was for 60 days. This study was conducted under the following steps- Selection of patients, General observation, Administration of drug, Follow up stud, Assessment.
Result: Comparing the symptomatic improvement in both groups it was found that average percentage of relief was higher in “Group A” (21.62%) followed by Group B (15.77%). It shows that effect of therapy was more in group A in comparison to Group B. It is due to the chronic nature of disease and study duration is only two months.
Conclusion:  Vatapittaja prakti, it was revealed in this study, predisposes more to Vyanga (Melasma). In a study comparing the effects of both medicines, Kinshukdi Taila and Vatapatrdi Lepa, on various signs and symptoms of Vyanga in two groups, it was discovered that “Group A” (21.62 percent) had a greater average percentage of alleviation than “Group B.” (15.77 percent).
Keywords: Melasma, Vatapittaja, Vyanga, Kinshukadi Taila, Vatapatradi Lepa.

  • XML
  • PDF 272.19 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 120
    • PDF Download: 305
European Journal of Molecular & Clinical Medicine
Volume 7, Issue 11
December 2020
Page 9161-9167
Files
  • XML
  • PDF 272.19 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 120
  • PDF Download: 305

APA

Dr. Preeti gawali, D. V. S. Y. D. Y. D. B. K. S. (2021). Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.. European Journal of Molecular & Clinical Medicine, 7(11), 9161-9167.

MLA

Dr. Vijay Singh Yadav, Dr. Yogesh, Dr. B. K sevatkar, Dr. Preeti gawali. "Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.". European Journal of Molecular & Clinical Medicine, 7, 11, 2021, 9161-9167.

HARVARD

Dr. Preeti gawali, D. V. S. Y. D. Y. D. B. K. S. (2021). 'Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.', European Journal of Molecular & Clinical Medicine, 7(11), pp. 9161-9167.

VANCOUVER

Dr. Preeti gawali, D. V. S. Y. D. Y. D. B. K. S. Etiopathological Study of Vyanga With Special Reference To Melasma And Therapeutic Trial of Kinshukadi Taila And Vatapatradi Lepa.. European Journal of Molecular & Clinical Medicine, 2021; 7(11): 9161-9167.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus